← Eichor
Study identifier: NCT06812390 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites

Condition: Cirrhosis · Ascites Hepatic  ·  Sponsor: Anahita Rabiee MD MHS

PhasePhase 2
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

A small, pilot proof-of-concept placebo-controlled trial to explore the effects of albumin on diuresis in patients with cirrhosis, ascites and lower extremity edema. We will additionally investigate albumin's effect on preventing neurohumoral activation, and acute kidney injury after diuresis.

This description comes directly from the study's public registry record.

Talk to the study team

Anahita Rabiee, MD, MHS  ·  203-932-5711  ·  anahita.rabiee@va.gov

Lynn F. Buchwalder, M.S.  ·  203-932-5711  ·  Lynn.Buchwalder@va.gov

Always discuss trial participation with your own doctor first.

Locations (1)

West Haven VA Medical CenterWest Haven, Connecticut, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06812390